Patrick Grossmann and the story of Invitris.
Invitris' launch presents Phactory as a platform for synthesising proteins from DNA using machinery derived from cells. Its founders identify bacteriophages as an initial application and explicitly seek partners in biopharmaceutical development, animal health and agriculture. The story concerns a production platform and the collaborations needed to develop products around it. Public launch statements about efficiency or possible treatments do not establish clinical outcomes or regulatory status.
Public advice & further reading.
No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.
Suggest a first-person interview or essay ↗Sources & attribution.
- 01Invitris — Y Combinator company and active founder profile
Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.
www.ycombinator.com
Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.
Request a correction or update ↗